ANCA-PR3 SERIN PROTEINASE 3 ANTIBODIES EIA Test
Test Cost: AED 420.0
Test Name:
ANCA-PR3 SERIN PROTEINASE 3 ANTIBODIES EIA Test
Components:
Corresponds with c-ANCA
Price:
AED 420.0
Sample Condition:
2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Overnight fasting is preferred.
Report Delivery:
Sample Tue / Thu / Sat by 9 am; Report Same day
Method:
Enzyme Immunoassay
Test Type:
Autoimmune disorders
Doctor:
Nephrologist, Physician, Neurologist
Test Department:
Pre Test Information:
No special preparation required
Test Details:
ANCA-PR3 (serine proteinase 3 antibodies) EIA test is a diagnostic test used to detect the presence of anti-neutrophil cytoplasmic antibodies (ANCA) targeting proteinase 3 (PR3) in the blood. This test is primarily used in the diagnosis and monitoring of certain autoimmune diseases, particularly granulomatosis with polyangiitis (GPA) or Wegener’s granulomatosis.
ANCA are autoantibodies that mistakenly attack the body’s own tissues, specifically the neutrophils (a type of white blood cell). PR3 is an enzyme found in the cytoplasmic granules of neutrophils, and when ANCA specifically target PR3, it can lead to inflammation and damage to blood vessels.
The ANCA-PR3 EIA test involves collecting a blood sample from the patient and then analyzing it in the laboratory. The test utilizes an enzyme immunoassay (EIA) technique to detect and quantify the levels of ANCA-PR3 antibodies in the blood. The results are reported as a numerical value, indicating the antibody levels present in the patient’s blood.
A positive result for ANCA-PR3 antibodies can suggest the presence of GPA or other related autoimmune diseases. However, a positive result alone is not sufficient for diagnosis, and further clinical evaluation and additional tests may be required. Conversely, a negative result does not rule out the possibility of these diseases, as ANCA-PR3 antibodies may not always be present or detectable.
Overall, the ANCA-PR3 (serine proteinase 3 antibodies) EIA test is a valuable tool in the diagnosis and management of autoimmune diseases, specifically GPA. It helps healthcare professionals in assessing disease activity, monitoring treatment response, and guiding therapeutic decisions.
| Test Name | ANCA-PR3 SERIN PROTEINASE 3 ANTIBODIES EIA Test |
|---|---|
| Components | Corresponds with c-ANCA |
| Price | 420.0 AED |
| Sample Condition | 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Overnight fasting is preferred. |
| Report Delivery | SampleTue / Thu / Sat by 9 am; Report Same day |
| Method | Enzyme Immunoassay |
| Test type | Autoimmune disorders |
| Doctor | Nephrologist, Physician, Neurologist |
| Test Department: | |
| Pre Test Information | No special preparation required |
| Test Details |
ANCA-PR3 (serine proteinase 3 antibodies) EIA test is a diagnostic test used to detect the presence of anti-neutrophil cytoplasmic antibodies (ANCA) targeting proteinase 3 (PR3) in the blood. This test is primarily used in the diagnosis and monitoring of certain autoimmune diseases, particularly granulomatosis with polyangiitis (GPA) or Wegener’s granulomatosis. ANCA are autoantibodies that mistakenly attack the body’s own tissues, specifically the neutrophils (a type of white blood cell). PR3 is an enzyme found in the cytoplasmic granules of neutrophils, and when ANCA specifically target PR3, it can lead to inflammation and damage to blood vessels. The ANCA-PR3 EIA test involves collecting a blood sample from the patient and then analyzing it in the laboratory. The test utilizes an enzyme immunoassay (EIA) technique to detect and quantify the levels of ANCA-PR3 antibodies in the blood. The results are reported as a numerical value, indicating the antibody levels present in the patient’s blood. A positive result for ANCA-PR3 antibodies can suggest the presence of GPA or other related autoimmune diseases. However, a positive result alone is not sufficient for diagnosis, and further clinical evaluation and additional tests may be required. Conversely, a negative result does not rule out the possibility of these diseases, as ANCA-PR3 antibodies may not always be present or detectable. Overall, the ANCA-PR3 (serine proteinase 3 antibodies) EIA test is a valuable tool in the diagnosis and management of autoimmune diseases, specifically GPA. It helps healthcare professionals in assessing disease activity, monitoring treatment response, and guiding therapeutic decisions. |
